Insmed, Inc. (INSM)
174.04
-0.05
(-0.03%)
USD |
NASDAQ |
Dec 31, 16:00
174.10
+0.06
(+0.03%)
After-Hours: 20:00
Insmed Research and Development Expense (TTM): 695.91M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Biogen, Inc. | 1.524B |
| Pfizer Inc. | 10.13B |
| Nektar Therapeutics | 116.36M |
| CorMedix, Inc. | 12.46M |